Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karo Pharma AB buy Needham & Company LLC

Start price
€5.44
16.07.25 / 50%
Target price
€51.67
16.07.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.07.26. The prediction end date can be changed by Needham___Company_LL at any time.
Performance without dividends (%)
Name 1w 1m
Karo Pharma AB - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

Comments by Needham___Company_LL for this prediction

In the thread Karo Pharma AB diskutieren
Prediction Buy
Perf. (%) -
Target price 51.672
Change
Ends at 16.07.26

Karooooo Ltd. (NASDAQ: KARO) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for KARO provided by MarketBeat